So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing tumor-specific immunity against multiple cancer types ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company focused on innovative drug delivery technologies, ...

ShreeGanesh Bio Standalone September 2024 Net Sales at Rs 1.98 crore, down 51.82% Y-o-Y Oct 24 2024 11:46 AM ShreeGanesh Bio Standalone June 2024 Net Sales at Rs 3.56 crore, down 56.92% Y-o-Y Aug ...

Genomic Valley Standalone June 2024 Net Sales at Rs 0.16 crore, up 165.24% Y-o-Y Jul 30 2024 02:19 PM Genomic Valley Standalone December 2023 Net Sales at Rs 0.04 crore, down 94.2% Y-o-Y Feb 16 ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3 1992. Effective 19th October 2020 the Company's name was changed to Kobo Biotech Limited ...

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992. Effective 19th October, 2020, the Companys name was changed to Kobo Biotech ...

Nykaa Q3 Profit Surges 51% to Rs 26.4 cr Nykaa's Q3 profit rose 51% to Rs 26.4 crore, driven by strong revenue growth across its beauty and fashion verticals. The company's consolidated revenue from ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...